New global efforts underscore a big push for precision medicine: a bright yet challenging future
In January of 2015, following years of rapid and exciting development in the field of genomics, the US government...
Effect of Statin Treatment in old and very old adults with Cardiovascular Disease with or without Diabetes
Cardiovascular disease (CVD) has become the worldwide leading cause of death. The most vulnerable section of the society to...
FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...
New Protocols for reducing Complications after Cardiac Surgery
Cardiac patients, undergoing a Cardiac Surgery like coronary artery bypass graft (CABG), aortic valve repair or replacement, tend to...
Liraglutide demonstrated CV benefits among Diabetes Drugs
Liraglutide (Victoza®) is an injectable glucagon-like peptide-1 (GLP-1) receptor antagonist indicated in addition to diet and exercise to improve...
Ertugliflozin Shows Promising Results as Therapy for Diabetes
The health and economic costs of diabetes are enormous. Considerable efforts are being made to develop new and more...